Our news

  • COVID-19 is especially dangerous for at risk populations, such as pregnant women. It is critical to determine how COVID-19 affects pregnant women and their babies. A regular systematic review methodology is not sufficient to synthesise the overwhelming amount of evidence produced daily worldwide. Cochrane Gynaecology and Fertility needed to carry...
    January 21 2021
  • The Cochrane review about antenatal steroids in reducing risk of infant mortality and morbidity is an important one in Cochrane's history. Cochrane's logo is based on the forest plot from the original publication in 1982. This review has recently been updated and lead author, Fiona Stewart, tells us how the logo might...
    December 29 2020
  • Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviewsA stillbirth is generally defined as the death of a baby before birth, at or after 24 weeks of development. It is most common in low‐ and middle‐income countries but also affects people in high‐income countries. Numbers of...
    December 23 2020
  • Read this recently published Cochrane review about CFTR correctors, a therapy for cystic fibrosis targeted at specific variants (most commonly F508del)In this review, the authors looked at drugs (or drug combinations) for correcting the basic defect in the most common cystic fibrosis (CF)-causing gene variant (F508del) and assessed their...
    December 17 2020
  • Cochrane Review: Early skin‐to‐skin contact for mothers and their healthy newborn infantsIn 2016, Cochrane Pregnancy and Childbirth published a systematic review looking at if skin-to-skin contact improved breastfeeding rates and helped babies adjust to the outside world. They looked at the results of 46 studies which included...
    November 18 2020
  • Special Collection: In vitro fertilisation - effectiveness of add-ons Infertility affects as many as 1 in 7 couples. Many of these people turn to fertility treatments for help. In vitro fertilisation (IVF) is generally considered the most advanced treatment option, and is recommended in many cases, regardless of the cause of subfertility....
    October 16 2020
  • WHO recommendations on drug treatment for non-severe hypertension in pregnancyCochrane has been a non-governmental organization in official relations with the World Health Organization (WHO) since 2011. WHO develops global health guidelines, which are of a high methodological quality and are developed through a transparent, evidence-based decision...
    September 8 2020
  • September is  Polycystic Ovary Syndrome Awareness Month and is an excellent time to focus on the latest Cochrane evidence.Polycystic ovary syndrome (PCOS) is a very common condition affecting 8% to 13% of women. Being overweight worsens all clinical features of PCOS. These clinical features include reproductive issues such as reduced...
    September 6 2020
  • Have your opinion heard!Help the Cochrane Pregnancy and Childbirth group with this short survey on prioritizing research topics.Visit the Cochrane Pregnancy and Childbirth website
    July 31 2020
  • A normal pregnancy lasts about 40 weeks (the gestation period) from the start of the woman's last menstrual period. If a pregnancy lasts too long, a woman and her clinician may wish to stimulate the woman’s body to begin labour. This is called induction.Babies may be at a greater risk of death, before or shortly after birth, after prolonged...
    July 15 2020

Pages

Subscribe to Our news